Sarepta Therapeutics, Inc. SRPT Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s contract liabilities, non-current?
- Sarepta Therapeutics, Inc. (SRPT) reported contract liabilities, non-current of $136.35M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s contract liabilities, non-current changed year-over-year?
- Sarepta Therapeutics, Inc.'s contract liabilities, non-current decreased by 58.0% year-over-year, from $325M to $136.35M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s contract liabilities, non-current?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s contract liabilities, non-current has grown at a -33.9% compound annual growth rate (CAGR), from $663.49M to $83.91M.